Dr. Richard Bockman, MD, PhD, is the Chief of the Endocrine Service at Hospital for Special Surgery and Professor of Medicine in the Endocrine Division at Weill Cornell Medical College since 1990. He is privileged to share the responsibilities of the clinical service with esteemed colleagues, Dr. Emily Stein who is in charge of the Endocrine Metabolic Bone Research Programs, and Drs. Jessica Starr and Katherine Haseltine in charge of the clinical programs.
As a Senior Scientist in the HSS Research Division, Dr. Bockman has directed basic and clinical research under NIH-sponsored grants and has published over 100 articles in many scientific and clinical journals, including Science, Journal of Clinical Investigation, Journal of Bone and Mineral Research, and Endocrinology.
Dr. Bockman is a Fellow of the American Society for Bone and Mineral Research (ASBMR-where he has served on the Professional Practice Committee and as the Society’s representative to FASEB ), and a Member of Endocrine Society (where he served on the Clinical Endocrine Update steering committee and Ethics Committee). He is a Fellow of the American College of Physicians, was elected to the American Society for Clinical Investigation and served six years on the editorial board of The Journal of Clinical Endocrinology and Metabolism and four years on an FDA advisory Committee and 3 years as a Director for the Advances in Mineral Metabolism Meeting, a mentoring venue for the ASBMR Haddad Fellows. Locally, Dr. Bockman serves on the Executive Committee of the NIH sponsored Endocrine Fellowship Committee at Weill Cornell and served many years on the Scientific Advisory Panel for the NIH funded Weill Cornell Clinical Translational Science Center and as the Vice Chair of the HSS Institutional Review Board.
The major objective of Dr. Bockman’s clinical and research efforts has been to elucidate the pathogenesis and genetic basis of metabolic bone diseases, including osteoporosis, and to develop new therapies for treating these disorders for the purpose of improving medical and surgical outcomes for HSS patients.
Dr. Bockman’s recent research has focused on clinical questions affecting the care of osteoporosis patients, including effects of specific pharmacologic therapies, and to expand our knowledge of the skeletal consequences of epidural steroids on bone metabolism. With a newly donated high-resolution peripheral CT-scanner, HSS is able to non-invasively establish the efficacy of treatment regimens within months as opposed to years with prior DXA methodologies. The team is rapidly initiating new collaborative studies with Medical and Orthopedic colleagues at HSS, NYPH and the larger NYC Medical Community. Dr. Bockman speaks for the Endocrine Service to express his profound appreciation to our patients, Donors, HSS Administration, Colleagues and Staff who have supported The Endocrine Service at HSS.
Contact : Bockman, Richard S
Fields marked with a star (*) are mandatory!